Connect Sign In
Assistant Professor (Clinical), University of Utah School of Medicine Specialties Molecular oncology Cytology Gynecologic pathology Education Medical Degree—Louisiana State University, Health Science Center Doctorate Degree—Louisiana State University, Health Science Center Residency—…
Assistant Professor (Clinical), University of Utah School of MedicineSubspecialties: Gastrointestinal and solid tumor molecular pathologyEducationMedical Degree—University of Toledo College of MedicineResidency—Anatomic and Clinical Pathology, Yale New Haven HospitalFellowship—Oncologic Surgical…
Professor, University of Utah School of MedicineSpecialtiesHematopathologyMolecular pathologyTranslational researchInnovationEducationMedical Degree—Harvard Medical SchoolDoctorate Degree—Harvard UniversityResidency—Anatomic Pathology, Stanford UniversityFellowship—Hematopathology, Stanford…
ARUP President and Chief Medical Officer Tracy George, MD, wants to establish a multidisciplinary, multinational network of centers focused on mast cell diagnosis, therapy, and education.
ARUP Consult® has released new and updated resources on Prenatal Testing for Chromosomal Abnormalities and Neural Tube Defects, Soft Tissue Sarcomas, and COVID.
ARUP Consult® added new resources in September that provide expert guidance on preoperative testing for ovarian cancer biomarkers and testing strategies for malaria.
GenomOncology announced that ARUP has chosen to extend its use of the GenomOncology (GO) Precision Oncology API Suite by integrating the GO Clinical Trial and Therapy Matching APIs into its workflows.
Associate Professor, University of Utah School of MedicineSpecialtiesHematopathology and hematology (benign and malignant)Molecular hematopathologyLymphomas (Hodgkin and non-Hodgkin)LeukemiasEducationMedical Degree—Baroda Medical College, Maharaja Sayajirao UniversityDoctorate Degree—Molecular…
SALT LAKE CITY—ARUP Laboratories today announced it has signed a strategic agreement with Massachusetts-based TellBio Inc. to use the development-stage biotechnology company’s TellDx circulating tumor cells (CTCs) technology in several research applications.
